NCT00448890View on ClinicalTrials.gov

Evaluation of Single and Repeat Doses of GSK729327 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Schizophrenia
Interventions
DRUG

GSK729327

Tablets

DRUG

Placebo

GSK729327 Matching placebo - Tablets

Trial Locations (2)

14050

GSK Investigational Site, Berlin

SE1 1YR

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY